Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ENTREMED (NQ: ENMD)
2.010 USD  +0.050 (+2.55%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about ENTREMED
 
< Previous 1 2 Next >
EntreMed, Inc. New (ENMD) Narrows Q1 Loss
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339331 for the full story. Read More
from StreetInsider.com News Articles
EntreMed's ENMD-2076 Awarded Patent In China
May 06, 2013
EntreMed, Inc. (NASDAQ: ENMD ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today announced the issuance by the Chinese State Intellectual... Read More
category Contracts , Management , ENMD , and 4 more.
from Latest Articles from Benzinga.com
EntreMed (ENMD) Appoints Ken Ren as CEO; Names Two Board Members
April 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8235398 for the full story. Read More
from StreetInsider.com News Articles
EntreMed, Inc. New (ENMD) Swings to Q4 Loss
March 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8202499 for the full story. Read More
from StreetInsider.com News Articles
The Week in Review: Sinopharm to Raise $640 Million through Bond Sale
March 09, 2013
Sinopharm Holdings, one of China’s big-three drug distributors, will issue $640 million of five-year corporate bonds that may be used to fund new acquisitions; Shanghai Fosun Pharma will buy $22.4... Read More
from ChinaBio® Today
Sabby Management Shows New 6.17% Stake in EntreMed (ENMD)
March 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8161323 for the full story. Read More
from StreetInsider.com News Articles
EntreMed Raises $10.7 Million from China-focused PE Funds
March 05, 2013
EntreMed, a US biotech with strong China connections, raised $10.7 million from two China-specific private equity funds: Kleiner Perkins Caufield Byers China Fund II LP and IDG-Accel China Growth Fund... Read More
from ChinaBio® Today
Unusual 11 Mid-Day Movers 02/26: (MNOV) (CWH) (ALC) Higher; (HSII) (VSI) (ENMD) Lower
February 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8133689 for the full story. Read More
from StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 02/25: (ENMD) (GALT) (APPY) Higher; (AFFY) (CEDC) (DVAX) Lower
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8128944 for the full story. Read More
from StreetInsider.com News Articles
Benzinga's Small Cap Movers for Wednesday January 23, 2013
January 23, 2013
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: EntreMed Shares of EntreMed (NASDAQ: ENMD ), the Rockville, MD clinical-stage pharmaceutical company, rose... Read More
category Benzinga , US6862751087 , Movers , and 11 more.
from Latest Articles from Benzinga.com
EntreMed (ENMD) Initiates ENMD-2076 Phase 2
January 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8024669 for the full story. Read More
from StreetInsider.com News Articles
Week in Review: China’s Joinn Labs Buys Major Biopharma Campus in San Francisco
January 12, 2013
Joinn Laboratories, a China pre-clinical CRO, is the mystery buyer of the ex-Bayer biopharma campus in the San Francisco Bay area; Fosun Pharma, executing its growth-by-acquisition strategy, paid $93... Read More
from ChinaBio® Today
Benzinga's Small Cap Movers for Monday January 7, 2013
January 07, 2013
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: EntreMed Shares of EntreMed (NASDAQ: ENMD ), the Rockville, MD clinical-stage pharmaceutical company, rose... Read More
category Benzinga , Movers , Global , and 12 more.
from Latest Articles from Benzinga.com
EntreMed Files to Begin Clinical Trial of Cancer Drug in China
January 07, 2013
EntreMed, a  Washington   DC- area biotech, has filed an application with the SFDA to begin clinical trials in  China  of its cancer treatment, ENMD-2076. The trial is a US-China Phase II test of the... Read More
from ChinaBio® Today
EntreMed Initiates Second Site For Phase 2 Trial In Triple-Negative Breast Cancer
January 04, 2013
EntreMed (NASDAQ: ENMD ) announced today the initiation of a second site for its Phase 2 study of ENMD-2076 in triple-negative breast cancer (TNBC). Kathy Miller, MD, Associate Professor at the Melvin... Read More
category Contracts , Management , ENMD , and 4 more.
from Latest Articles from Benzinga.com
EntreMed (ENMD) Announces Initiation of Second Site For Phase 2 Trial In TNBC
January 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7985390 for the full story. Read More
from StreetInsider.com News Articles
Benzinga's Small Cap Movers for Monday November 26, 2012
November 26, 2012
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Oclaro Shares of Oclaro (NASDAQ: OCLR ), the San Jose, CA provider of lasers and optical components, rose... Read More
category Benzinga , US67555N2062 , Movers , and 16 more.
from Latest Articles from Benzinga.com
Ubika Research’s Daily US Box Score: Top Junior Industrials (NASDAQ GM: CBAK) Stock Gained 54%
November 26, 2012
from ACCESSWIRE
Unusual 11 Mid-Day Movers 11/26: (CBAK) (ENMD) (ANAD) Higher; (MMR) (CCCL) (OXF) Lower
November 26, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7902212 for the full story. Read More
from StreetInsider.com News Articles
EntreMed Shares Surge as Results from Preclinical Trial for ENMD-2076 Published
November 26, 2012
EntreMed (NASDAQ: ENMD ) announced today the publication of favorable results of a preclinical study in breast cancer of its oral Aurora A/angiogenic kinase inhibitor, ENMD-2076. The article, entitled... Read More
category ENMD , Benzinga , Movers , and 2 more.
from Latest Articles from Benzinga.com
Morning Market Movers
November 26, 2012
Inuvo (AMEX: INUV) climbed 35.04% to $1.80 at 9:45 am. Inuvo's trailing-twelve-month revenue is $43.73 million. EntreMed (NASDAQ: ENMD ) surged 17.27% to $1.63. EntreMed announced the publication of... Read More
category INUV , Benzinga , Movers , and 11 more.
from Latest Articles from Benzinga.com
EntreMed, Inc. (ENMD) Reports Q3 Loss of $0.05
November 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7874363 for the full story. Read More
from StreetInsider.com News Articles
EntreMed (ENMD) Files $30M Securities Shelf
September 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7755352 for the full story. Read More
from StreetInsider.com News Articles
EntreMed, Inc. New (ENMD) Widens Q2 Loss to 56c/Share
August 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7656326 for the full story. Read More
from StreetInsider.com News Articles
EntreMed (ENMD) Initiates Phase 2 Trial In Triple-negative Breast Cancer
July 25, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7601924 for the full story. Read More
from StreetInsider.com News Articles
EntreMed (ENMD) Files 10.56M Common Shelf for Shareholders
July 23, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7597188 for the full story. Read More
from StreetInsider.com News Articles
EntreMed, Inc. (ENMD) Narrows Q1 Loss to 23c/Share
May 15, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7437721 for the full story. Read More
from StreetInsider.com News Articles
Ken Ren Becomes Interim CEO at EntreMed (ENMD)
April 03, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7316949 for the full story. Read More
from StreetInsider.com News Articles
The Week in Review: Abcam Pays $170 Million for China-Connected Epitomics
March 10, 2012
Abcam will pay $170 million to buy Epitomics, a US mAb pharma with a China manufacturing facility; Jiangxi Boya Bio-Pharma completed a $60 million IPO on the ChiNext exchange; 3SBio will form a $20... Read More
from ChinaBio® Today
EntreMed, Inc. New (ENMD) Reports Q4 Earnings of $0.06
March 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7255744 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here